JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halleen, J. M.
Right arrow Articles by Väänänen, H. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halleen, J. M.
Right arrow Articles by Väänänen, H. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 33, 22907-22910, August 13, 1999

COMMUNICATION
Intracellular Fragmentation of Bone Resorption Products by Reactive Oxygen Species Generated by Osteoclastic Tartrate-resistant Acid Phosphatase*

Jussi M. HalleenDagger , Seija RäisänenDagger , Jari J. Salo§, Sakamuri V. Reddy, G. David Roodman, Teuvo A. HentunenDagger , Petri P. Lehenkariparallel , Helena Kaija**, Pirkko Vihkoddager ddager , and H. Kalervo VäänänenDagger §§

From the Dagger  Institute of Biomedicine, Department of Anatomy, University of Turku, FIN-20520 Turku, Finland, § Department of Orthopaedics and Traumatology, Helsinki University Central Hospital, FIN-00260 Helsinki, Finland,  Department of Medicine and Hematology, University of Texas Health Science Center, San Antonio, Texas 78284-7880, parallel  Bone and Mineral Centre, The Rayne Institute, London WC1E 6JJ, United Kingdom, ** Biocenter Oulu and World Health Organization Collaborating Centre for Research on Reproductive Health, University of Oulu, FIN-90220 Oulu, Finland, and §§ Department of Biosciences, University of Helsinki, FIN-00014 Helsinki, Finland

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Tartrate-resistant acid phosphatase (TRAP) is highly expressed in bone-resorbing osteoclasts and activated macrophages. It has been suggested that a redox-active iron in the binuclear iron center of TRAP could have the capacity to react with hydrogen peroxide to produce highly destructive reactive oxygen species (ROS). Here we show that TRAP can generate ROS in vitro and that cells over-expressing TRAP produce higher amounts of intracellular ROS than their parent cells. We further demonstrate that these ROS can be targeted to destroy collagen and other proteins. In resorbing osteoclasts, TRAP was found in transcytotic vesicles transporting matrix degradation products through the cell, suggesting that TRAP-facilitated fragmentation of endocytosed material takes place in a specific cellular compartment. These results suggest that bone matrix degradation occurs not only extracellularly in the resorption lacunae but also intracellularly in the transcytotic vesicles. We propose that proteins containing redox-active iron could represent a novel mechanism of physiological fragmentation of organic molecules. This mechanism could be important in tissue remodeling and as a defense mechanism of phagocytosing cells.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

During bone growth and remodeling, a remarkable amount of bone is degraded by osteoclasts that have developed an efficient machinery to break down inorganic and organic bone matrix (1). Crucial components of this machinery are the secretions of acid and proteinases into an extracellular resorption lacuna (2-5). Resorbing osteoclasts are highly polarized and reveal at least four different membrane domains (5). Ruffled border (RB)1 forms the actual resorbing organ and penetrates into bone matrix with continuous endocytosis and transcytosis of degraded matrix components (6, 7). Finally, resorption products are secreted to the extracellular space via a functional secretory domain (FSD) in the basolateral membrane (8). In addition to active acidification and production of various proteinases, osteoclasts produce high amounts of reactive oxygen species (ROS) during resorption (9). However, the source and exact role of ROS have remained unclear.

Tartrate-resistant acid phosphatase (TRAP) is widely used as a specific marker for osteoclasts (10). High amounts of TRAP are also expressed in lung macrophages and in the hairy cells of the spleen in hairy cell leukemia (11). TRAP contains a binuclear iron center (12, 13), which has been suggested to participate in the generation of hydroxyl radicals (·OH) (14, 15). The function and subcellular localization of TRAP have remained unclear despite extensive biochemical characterization and production of knock-out animals. Aging TRAP-/- mice revealed mild osteopetrosis (excess accumulation of bone) despite having a normal number and morphology of osteoclasts (16). To learn the physiological function of TRAP, we hypothesized that TRAP could facilitate the formation of ·OH and target those ·OH to break down extracellular matrix components during bone resorption.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Detection of Hydroxyl Radicals-- Hydroxyl radical formation was monitored by following the formation of malondialdehyde acetal (MDA) from deoxyribose as described earlier (17). Recombinant rat bone TRAP (18, 19) was incubated for 1 h at 37 °C in a 1.0-ml reaction mixture containing 10 mM deoxyribose, 0.1 mM ascorbate, 1 mM hydrogen peroxide, 5 µg (1 unit) of aprotinin, and 1 mM phenylmethylsulfonyl fluoride in phosphate-buffered saline, pH 7.2. Ferric EDTA (0.1 mM FeCl3 in 0.2 mM EDTA) was used as a positive control and transferrin, carbonic anhydrase II (CA II), and matrix metalloproteinase 9 (MMP-9) as negative controls. Formation of ·OH was further studied by adding various amounts of mannitol, a scavenger of ·OH (17), to the reaction mixture containing TRAP. Color was developed by heating for 15 min at 100 °C in thiobarbituric acid and trichloroacetic acid as described (17).

Over-expression of TRAP-- The Pg-TRAP plasmid was constructed by cloning reverse transcriptase-polymerase chain reaction-cloned TRAP cDNA from human osteoclast-like cells into pCI Neo mammalian expression vector (Promega, Madison, WI) at the EcoRI site. This construct was transfected into murine macrophage-like RAW-264 cells using a cationic liposome reagent (Roche Molecular Biochemicals). Transfected cells were selected with 400 mg/ml geneticin (G418, Calbiochem-Novabiochem, San Diego, CA) over 14 days. Isolated clones were maintained in 200 mg/ml geneticin.

Measurement of Intracellular Oxidized State-- Intracellular ROS were detected using the fluorescent probe DCFH-DA (Molecular Probes, Eugene, OR) (20). Cells were grown on glass coverslips, incubated for 5 min in Hanks' solution (Life Technologies Inc.) containing 5 mM DCFH-DA, briefly rinsed in Hanks' solution, and kept at +37 °C during the measurement. Cells were excited with a 495 nm wavelength using a computer-driven filter wheel (MAC 2000, Ludl Electronic Products, New York) and a 32D neutral filter to avoid UV-induced radical production. Emitted light was collected through a dichroic mirror and an interference filter at 510 nm. Fluorescence was quantitated using an MCID image analyzer utilizing M2 software (Imaging research Inc., Brock University, Ste. Catharines, Ontario, Canada) as described (21).

Osteoclast Culture and Immunofluorescence Microscopy-- Rat bone cells were cultured for 24 h on bovine bone slices as described (22) and fixed with 3% paraformaldehyde containing 0.2% Triton X-100. Cells were incubated with mouse TRAP antiserum (1:1000 in 0.5% bovine serum albumin/Tris-buffered saline) for 2 h (23). TRAP was visualized using rhodamine-conjugated anti-mouse IgG (Dakopatts, Glostrup, Denmark). RB was visualized using fluorescein isothiocyanate-labeled PNA-lectin (Sigma) (24). Biotinylated organic bone matrix components were visualized as described (7). Bone slices were washed, embedded with 50% glycerol, and examined under a light microscope equipped with appropriate filters (Leitz Aristoplan, Wetzlar, Germany). Fluorescent images were photographed on Agfa Pan 400 film. Confocal microscopy was performed using confocal laser scanning microscope (Leica Lasertechnic, Heidelberg, Germany) equipped with a multiline 750-milliwatt Omnichrome argon-krypton laser (Omnichrome, Chino. CA).

Monitoring of Collagen Breakdown-- Type I collagen (Fluka, Buchs, Switzerland) was purified from low molecular weight impurities by gel filtration using Superdex 200 HR 10/30 gel filtration column equilibrated with 10 mM Tris-HCl, pH 8.2, containing 0.3 M NaCl, using HPLC equipment (Amersham Pharmacia Biotech). 100 µg of the purified collagen was incubated for 1 h at 37 °C in a reaction mixture containing 80 nM TRAP, 0.1 mM ascorbate, 1 mM hydrogen peroxide, 5 µg (1 unit)/ml aprotinin, and 1 mM phenylmethylsulfonyl fluoride in phosphate-buffered saline, pH 7.2. After the reaction, a 0.5-ml aliquot was immediately chromatographed through Superdex 200 HR 10/30 gel filtration column as described above. Similar experiments were also performed with ferric EDTA and transferrin. Controls were as indicated under "Results."

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

TRAP Generates ROS-- TRAP and EDTA-chelated iron were approximately equally potent in facilitating ·OH formation from H2O2, whereas transferrin did not generate ·OH in the deoxyribose system (Fig. 1A). Two zinc-containing osteoclast enzymes involved in bone resorption, CA II and MMP-9, were also unable to generate ·OH (Fig. 1B). The results shown in Fig. 1B were not affected if protease inhibitors were omitted from the reaction mixture (data not shown). The ·OH scavenger mannitol decreased the amount of MDA formation in the presence of TRAP (data not shown). We calculated the rate constant for the reaction of mannitol with ·OH as described earlier (17) and obtained a value of 1.7 × 109 M-1 s-1, which is in accordance with the rate constant 1.0-2.0 × 109 M-1 s-1 obtained earlier for mannitol using EDTA-chelated iron as a generator of ·OH in the deoxyribose system (17). RAW-264 cells over-expressing TRAP had a significantly higher basal production of ROS than their parent cells (Fig. 1C).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 1.   TRAP generates hydroxyl radicals. A, the ability of EDTA-chelated iron, recombinant rat bone TRAP, and transferrin to generate ·OH was detected by measuring the formation of MDA from deoxyribose fragments in the presence of H2O2. A532, which is directly proportional to the amount of MDA formed versus the amount of iron (µM) present in each measurement, is given. B, comparison of the ability of TRAP, CA II, and MMP-9 to generate ·OH. A532 after each reaction is shown. C, RAW-264 cells over-expressing TRAP have significantly higher basal production of intracellular ROS than their parent cells. Intracellular ROS were detected from 50 RAW-264 cells over-expressing TRAP and from 50 of their parent cells using the fluorescent probe DCFH-DA. The mean ± S.D. of relative optical density (ROD) of intracellular fluorescence is given.

Intracellular Localization of TRAP in Osteoclasts-- We studied the distribution of TRAP in resorbing osteoclasts and noticed that TRAP was not localized in RB (Fig. 2, A and B). Instead, it was co-localized to intracellular vesicles containing endocytosed organic bone degradation products released from bone matrix during resorption (Fig. 2C; see Ref. 7).


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 2.   Laser scanning confocal microscopy was used to study the localization of TRAP in resorbing osteoclasts. A and B, double staining of resorbing osteoclasts by TRAP and PNA-lectin demonstrated the following: the upper part of the cells contains numerous large TRAP-containing vesicles (A, red color, indicated by arrows), which are not found in the ruffled border area stained by PNA-lectin (B, green color). C, to reveal the presence of intracellular organic bone degradation products, osteoclasts were cultured on biotinylated bone slices (7). Double-staining of TRAP (red color) with biotin (green color) revealed several large intracellular vesicles with co-localization (yellow color, indicated by arrows). Dotted lines indicate cell borders (A-C). Scale bars (B and C) = 10 µm.

ROS Generated by TRAP Destroy Type I Collagen-- On the basis of TRAP's capacity to facilitate ROS formation and its localization in the transcytotic vesicles, we hypothesized that ROS generated by TRAP could directly damage type I collagen and other proteins. To test the hypothesis, we used the same conditions in demonstrating the generation of hydroxyl radicals by TRAP (see Fig. 1A) and replaced deoxyribose with type I collagen. The Mr of type I collagen incubated in the reaction mixture without trap was > 1000, and the Mr of trap incubated without type I collagen was 32 (data not shown). When type I collagen and trap were incubated together without H2O2, their Mr did not change (Fig. 3A). The addition of H2O2 resulted in fragmentation of most of the type I collagen into small fragments with Mr <10, whereas the Mr of trap did not change (Fig. 3B). Experiments in which albumin was used instead of collagen revealed similar results (data not shown). Similarly to TRAP, EDTA-chelated iron efficiently destroyed collagen, whereas transferrin had no effect (data not shown), as suggested based on the deoxyribose test (see Fig. 1A).


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 3.   HPLC Superdex 200 gel filtration was used to study the ability of ·OH formed by recombinant TRAP to destroy type I collagen. A, when type I collagen and TRAP were incubated together without H2O2, type I collagen eluted in the void volume, and trap eluted in fractions corresponding with Mr 32. B, the addition of H2O2 resulted in fragmentation of most of the type I collagen to small fragments with Mr < 10, whereas TRAP still eluted as described in A.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Osteoclasts take up resorbed bone material, which is transported through the cell and secreted through FSD (6, 7). This transcytotic route explains how osteoclasts are able to remove large amounts of matrix degradation products and simultaneously penetrate into bone. We show here that in resorbing osteoclasts, TRAP is localized in transcytotic vesicles and not in RB or in the resorption lacuna. Our results are in good agreement with those published earlier by Clark and co-workers (25), who demonstrated by immunoelectron microscopy that TRAP is localized in large cytoplasmic vesicles and not in RB. We suggest that TRAP-containing vesicles from the biosynthetic pathway are fused to transcytotic vesicles transporting matrix degradation products from RB to FSD, where the enzyme is secreted together with the matrix degradation products. Based on our results, we hypothesize that the physiological function of TRAP in osteoclasts is to destroy endocytosed matrix degradation products during their transcytosis. Thus, matrix degradation would occur not only extracellularly in the resorption lacunae but also intracellularly in the transcytotic vesicles.

TRAP knock-out mice show disrupted endochondral ossification and mild osteopetrosis (16). If our hypothesis were correct, TRAP would not have any effect on the attachment of osteoclasts to bone in the normal bone remodeling cycle. Nor would TRAP affect development of the RB, acidification of the resorption lacuna, degradation of bone matrix in the resorption lacunae, or endocytosis of dissolved bone material. The only effect would be on the processing of the endocytosed matrix components during transcytosis. Thus, inactivation of TRAP would most probably result in only a small decrease in bone resorption, which would be in good agreement with the observed mild osteopetrosis in TRAP knock-out mice.

Bone resorption produces various breakdown products of bone matrix components into serum and urine (26). Clinical studies indicate that stimulated bone resorption leads to increased levels of TRAP in the serum (23, 27, 28), suggesting that osteoclasts would secrete TRAP into the circulation during bone resorption, where it is found intact in a large calcium-containing complex (28). Our results show that TRAP-facilitated ROS formation leads to fragmentation of collagen and other proteins. However, TRAP molecules themselves are not targets for this fragmentation. This result is in accordance with the in vivo findings that matrix proteins such as collagen, but not TRAP, are found as small fragments in the circulation (26, 28).

Our results clearly demonstrate that TRAP is capable of generating ROS that can destroy proteins in vitro. This activity of TRAP was not inhibited by protease inhibitors, and a similar activity was not observed in the same conditions for transferrin, an iron-containing protein without redox-active iron, and for CA II and MMP-9, two zinc-containing osteoclast enzymes involved in bone resorption. Instead, a similar activity was observed for EDTA-chelated redox-active iron. These observations suggest that the redox-active iron in TRAP would be active in generating ROS. The fact that the TRAP over-expressing cells produce high amounts of ROS further supports this hypothesis, although it is possible that some amount of the ROS in the cells is generated because of cell damage.

Iron-catalyzed ·OH formation from hydrogen peroxide by the Fenton reaction is well known to cause DNA damage (29). Hydroxyl radicals also affect proteins by destroying the peptide backbone and by attacking some amino acid side chains, resulting in the fragmentation of proteins and the formation of aggregates (30, 31). Instead, ·OH in combination with the superoxide anion (Obardot 2) cause protein fragmentation without the formation of aggregates (30). Our results demonstrate the fragmentation of proteins by ·OH generated by TRAP without aggregate formation, suggesting that Obardot 2 would also be present in the reaction mixture. When the redox-active iron in the binuclear iron center of TRAP is in the ferrous form, it can react with H2O2 by the Fenton reaction to produce a ferric ion and ·OH: Fe2+ + H2O2 right-arrow Fe3+ + OH-+ ·OH. The newly formed ferric ion is still redox-active and able to react with H2O2 to form Obardot 2 and a ferrous ion: Fe3+ + H2O2 right-arrow Fe2+ + 2 H+ + Obardot 2. The formed ferrous ion is again able to react by the Fenton reaction etc. Thus, a sequence of reactions generating both ·OH and Obardot 2 occurs with continuous oxidation and reduction of the redox-active iron, making it possible for one enzyme molecule to generate a high number of these ROS as long as H2O2 is available.

In addition to osteoclasts, activated macrophages such as alveolar macrophages of the lung express high amounts of TRAP in normal human tissues (11). We have reported earlier that the enzymes purified from these two cell types have identical catalytic properties, suggesting that TRAP would have a similar physiological function in both osteoclasts and macrophages (18). The transcytotic route in osteoclasts represents a transport route from a late-endosome or lysosome-type compartment (RB membrane) to the cell surface. Another example of such a route is the transport route operating during antigen processing before presentation in macrophages. The mechanisms involved in antigen processing are not known. We hypothesize that TRAP could function in activated macrophages in the antigen presentation route generating ROS that would be targeted in antigen processing.

The role of ROS in the physiological degradation of the extracellular matrix and in tissue remodeling is unknown. Our results demonstrate that in specific cellular compartments of osteoclasts, TRAP-facilitated ROS production can be targeted to destroy extracellular matrix proteins. We propose that the family of proteins containing redox-active iron could represent a novel mechanism of physiological fragmentation in organic molecules. This mechanism could be important in tissue remodeling and as a defense mechanism of phagocytosing cells.

    FOOTNOTES

* This work was supported by grants from the Academy of Finland, State Technology Development Center of Finland (TEKES), and the Sigrid Juselius Foundation. World Health Organization Collaborating Center for Research on Reproductive Health is supported by the Ministry of Education, Social Affairs and Health and the Ministry of Foreign Affairs, Finland.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§§ To whom correspondence should be addressed. Tel.: 358-2-333 7232; Fax: 358-2-333 7352; E-mail: kalervo.vaananen@utu.fi.

    ABBREVIATIONS

The abbreviations used are: RB, ruffled border; FSD, functional secretory domain; ROS, reactive oxygen species; TRAP, tartrate-resistant acid phosphatase; MDA, malondialdehyde acetal; CA II, carbonic anhydrase II; MMP-9, matrix metalloproteinase 9; DCFH-DA, 2',7'-dichlorofluorescin diacetate.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Blair, H. C., Kahn, A. J., Crouch, E. C., Jeffrey, J. J., and Teitelbaum, S. L. (1986) J. Cell Biol. 102, 1164-1172[Abstract/Free Full Text]
2. Baron, R., Neff, L., Brown, W., Courtoy, P. J., Louvard, D., and Farquhar, M. G. (1988) J. Cell Biol. 106, 1863-1872[Abstract/Free Full Text]
3. Blair, H. C., Teitelbaum, S. L., Ghiselli, R., and Gluck, S. (1989) Science 245, 855-857[Abstract/Free Full Text]
4. Väänänen, H. K., Karhukorpi, E. K., Sundquist, K., Wallmark, B., Roininen, I., Hentunen, T., Tuukkanen, J., and Lakkakorpi, P. (1990) J. Cell Biol. 111, 1305-1311[Abstract/Free Full Text]
5. Väänänen, H. K. (1996) in Principles of Bone Biology (Bilezikian, J. P. , Raisz, L. G. , and Rodan, G. A., eds) , pp. 103-113, Academic Press, San Diego, CA
6. Nesbitt, S. A., and Horton, M. A. (1997) Science 276, 266-269[Abstract/Free Full Text]
7. Salo, J. J., Lehenkari, P., Mulari, M., Metsikkö, K., and Väänänen, H. K. (1997) Science 276, 270-273[Abstract/Free Full Text]
8. Salo, J., Metsikkö, K., Palokangas, H., Lehenkari, P., and Väänänen, H. K. (1996) J. Cell Sci. 106, 301-307
9. Silverton, S. (1994) J. Cell. Biochem. 56, 367-373[CrossRef][Medline] [Order article via Infotrieve]
10. Minkin, C. (1982) Calcif. Tissue Int. 34, 285-290[CrossRef][Medline] [Order article via Infotrieve]
11. Yaziji, H., Janckila, A. J., Lear, S. C., Martin, A. W., and Yam, L. T. (1995) Am. J. Clin. Pathol. 104, 397-402[Medline] [Order article via Infotrieve]
12. Davis, J. C., and Averill, B. A. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 4623-4627[Abstract/Free Full Text]
13. Doi, K., Antanaitis, B. C., and Aisen, P. (1988) Struct. Bonding 70, 1-26
14. Sibille, J.-C., Doi, K., and Aisen, P. (1987) J. Biol. Chem. 262, 59-62[Abstract/Free Full Text]
15. Hayman, A. R., and Cox, T. M. (1994) J. Biol. Chem. 269, 1294-1300[Abstract/Free Full Text]
16. Hayman, A. R., Jones, S. J., Boyde, A., Foster, D., Colledge, W. H., Carlton, M. B., Evans, M. J., and Cox, T. M. (1996) Development 122, 3151-3162[Abstract]
17. Halliwell, B., Gutteridge, J. M. C., and Aruoma, O. I. (1987) Anal. Biochem. 165, 215-219[CrossRef][Medline] [Order article via Infotrieve]
18. Halleen, J. M., Kaija, H., Stepan, J. J., Salo, J. J., Vihko, P., and Väänänen, H. K. (1998) Arch. Biochem. Biophys. 352, 97-102[CrossRef][Medline] [Order article via Infotrieve]
19. Vihko, P., Kurkela, R., Porvari, K., Herrala, A., Lindfors, A., Lindqvist, Y., and Schneider, G. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 799-803[Abstract/Free Full Text]
20. Ohba, M., Shibanuma, M., Kuroki, T., and Nose, K. (1994) J. Cell Biol. 126, 1079-1088[Abstract/Free Full Text]
21. Lehenkari, P. P., Laitala-Leinonen, T., Linna, T.-J., and Väänänen, H. K. (1997) Biochem. Biophys. Res. Commun. 235, 838-844[CrossRef][Medline] [Order article via Infotrieve]
22. Lakkakorpi, P. T., Tuukkanen, J., Hentunen, T., Järvelin, K., and Väänänen, K. (1989) J. Bone Miner. Res. 4, 817-825[Medline] [Order article via Infotrieve]
23. Halleen, J., Hentunen, T. A., Hellman, J., and Väänänen, H. K. (1996) J. Bone Miner. Res. 11, 1444-1452[Medline] [Order article via Infotrieve]
24. Takagi, M., Yakasaki, H., and Baba, H. (1988) J. Histochem. Cytochem. 36, 95-101[Abstract]
25. Clark, SA, Ambrose, W. W., Anderson, T. R., Terell, R. S., and Toverud, S. U. (1989) J. Bone Miner. Res. 4, 399-405[Medline] [Order article via Infotrieve]
26. Garnero, P., and Delmas, P. D. (1996) in Principles of Bone Biology (Bilezikian, J. P. , Raisz, L. G. , and Rodan, G. A., eds) , pp. 1277-1291, Academic Press, San Diego, CA
27. Kraenzlin, M. E., Lau, K. H. W., Liang, L., Freeman, T. K., Singer, F. R., Stepan, J., and Baylink, D. J. (1990) J. Clin. Endocrinol. Metab. 71, 442-451[Abstract]
28. Halleen, J. M., Hentunen, T. A., Karp, M., Käkönen, S.-M., Pettersson, K., and Väänänen, H. K. (1998) J. Bone Miner. Res. 13, 683-687[CrossRef][Medline] [Order article via Infotrieve]
29. Henle, E. S., and Linn, S. (1997) J. Biol. Chem. 272, 19095-19098[Free Full Text]
30. Davies, K. J. A., and Delsignore, M. E. (1987) J. Biol. Chem. 262, 9908-9913[Abstract/Free Full Text]
31. Berlett, B. S., and Stadtman, E. R. (1997) J. Biol. Chem. 272, 20313-20316[Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Chem.Home page
M. J. Valimaki and R. Tahtela
Serum Tartrate-Resistant Acid Phosphatase 5b or Amino-Terminal Propeptide of Type I Procollagen for Monitoring Bisphosphonate Therapy in Postmenopausal Osteoporosis?
Clin. Chem., December 1, 2005; 51(12): 2382 - 2385.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Ljusberg, Y. Wang, P. Lang, M. Norgard, R. Dodds, K. Hultenby, B. Ek-Rylander, and G. Andersson
Proteolytic Excision of a Repressive Loop Domain in Tartrate-resistant Acid Phosphatase by Cathepsin K in Osteoclasts
J. Biol. Chem., August 5, 2005; 280(31): 28370 - 28381.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. J. Pavlos, J. Xu, D. Riedel, J. S. G. Yeoh, S. L. Teitelbaum, J. M. Papadimitriou, R. Jahn, F. P. Ross, and M. H. Zheng
Rab3D Regulates a Novel Vesicular Trafficking Pathway That Is Required for Osteoclastic Bone Resorption
Mol. Cell. Biol., June 15, 2005; 25(12): 5253 - 5269.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. E.T. da Costa, N. E. Annels, C. M.J.M. Faaij, R. G. Forsyth, P. C.W. Hogendoorn, and R. M. Egeler
Presence of osteoclast-like multinucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis
J. Exp. Med., March 7, 2005; 201(5): 687 - 693.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. J. Janckila, R. N. Parthasarathy, L. K. Parthasarathy, R. S. Seelan, Y.-C. Hsueh, J. Rissanen, S. L. Alatalo, J. M. Halleen, and L. T. Yam
Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells
J. Leukoc. Biol., February 1, 2005; 77(2): 209 - 218.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. L. Alatalo, K. K. Ivaska, S. G. Waguespack, M. J. Econs, H. K. Vaananen, and J. M. Halleen
Osteoclast-Derived Serum Tartrate-Resistant Acid Phosphatase 5b in Albers-Schonberg Disease (Type II Autosomal Dominant Osteopetrosis)
Clin. Chem., May 1, 2004; 50(5): 883 - 890.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K. W. Dwyer, P. P. Provenzano, P. Muir, W. B. Valhmu, and R. Vanderby Jr.
Blockade of the sympathetic nervous system degrades ligament in a rat MCL model
J Appl Physiol, February 1, 2004; 96(2): 711 - 718.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. A. J. van de Loo, M. B. Bennink, O. J. Arntz, R. L. Smeets, E. Lubberts, L. A. B. Joosten, P. L. E. M. van Lent, C. J. J. Coenen-de Roo, S. Cuzzocrea, B. H. Segal, et al.
Deficiency of NADPH Oxidase Components p47phox and gp91phox Caused Granulomatous Synovitis and Increased Connective Tissue Destruction in Experimental Arthritis Models
Am. J. Pathol., October 1, 2003; 163(4): 1525 - 1537.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
A. J. Janckila, W.-K. Yang, R.-J. Lin, C.-J. Tseng, H.-Y. Chang, J.-M. Chang, and L. T. Yam
Flow Cytoenzymology of Intracellular Tartrate-resistant Acid Phosphatase
J. Histochem. Cytochem., September 1, 2003; 51(9): 1131 - 1135.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Liu, Z. Shi, A. Silveira, J. Liu, M. Sawadogo, H. Yang, and X. Feng
Involvement of Upstream Stimulatory Factors 1 and 2 in RANKL-induced Transcription of Tartrate-resistant Acid Phosphatase Gene during Osteoclast Differentiation
J. Biol. Chem., May 30, 2003; 278(23): 20603 - 20611.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. G. Waguespack, S. L. Hui, K. E. White, K. A. Buckwalter, and M. J. Econs
Measurement of Tartrate-Resistant Acid Phosphatase and the Brain Isoenzyme of Creatine Kinase Accurately Diagnoses Type II Autosomal Dominant Osteopetrosis but Does Not Identify Gene Carriers
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2212 - 2217.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
H Bull, P G Murray, D Thomas, A M Fraser, and P N Nelson
Acid phosphatases
Mol. Pathol., April 1, 2002; 55(2): 65 - 72.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
A. R. Hayman, P. Macary, P. J. Lehner, and T. M. Cox
Tartrate-resistant Acid Phosphatase (Acp 5): Identification in Diverse Human Tissues and Dendritic Cells
J. Histochem. Cytochem., June 1, 2001; 49(6): 675 - 684.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
S. L. Alatalo, J. M. Halleen, T. A. Hentunen, J. Monkkonen, and H. K. Vaananen
Rapid Screening Method for Osteoclast Differentiation in Vitro That Measures Tartrate-resistant Acid Phosphatase 5b Activity Secreted into the Culture Medium
Clin. Chem., November 1, 2000; 46(11): 1751 - 1754.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
A. R. Hayman, A. J. Bune, J. R. Bradley, J. Rashbass, and T. M. Cox
Osteoclastic Tartrate-resistant Acid Phosphatase (Acp 5): Its Localization to Dendritic Cells and Diverse Murine Tissues
J. Histochem. Cytochem., February 1, 2000; 48(2): 219 - 228.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
H. Vaananen, H Zhao, M Mulari, and J. Halleen
The cell biology of osteoclast function
J. Cell Sci., January 2, 2000; 113(3): 377 - 381.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halleen, J. M.
Right arrow Articles by Väänänen, H. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halleen, J. M.
Right arrow Articles by Väänänen, H. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.